Exoxemis Exoxemis - Collaborations
Home Technology Indications Collaborations Company Publications Contact
Exoxemis as a Partner Licensing
 
>

Exoxemis as a Partner

Applying highest quality science, research, and development to our partnerships and collaborations.

 
       
>

Licensing

We leverage our proprietary know-how and technology platform through product licensing and collaborations in areas of unmet clinical need. more >>

   
       
>

E-mail Inquiries

   

Exoxemis as a Partner

Exoxemis is focused on the development of haloperoxidase enzyme-based products to address the increasing threat of serious and drug-resistant infections. We are committed to:

  • Leveraging expertise in enzymology, bioanalytical methods, microbiology, and formulation sciences to bring new products to market.
  • Applying highest quality science, research, and development to our partnerships and collaborations.
  • Supporting scholarship and innovation in evolving applications of our technology.
  • Targeting product opportunities to address areas of high, unmet clinical demand, and strong potential market growth.
  • Extending the application of the myeloperoxidase and eosinophil peroxidase technology platform to a wide variety of medical, veterinary, agricultural, disinfectant, and industrial applications.
  • Offering flexibility in formulation to accommodate multiple indications and provide a cGMP-manufactured product
  • Delivering value to partners and collaborators.